Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bonjour J. P., Philippe J., Guelpa G., Bisetti A., Rizzoli R., Jung A., Rosini S., Kanis J. A. Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate. Bone. 1988;9(3):123–130. doi: 10.1016/8756-3282(88)90001-4. [DOI] [PubMed] [Google Scholar]
- Hasling C., Charles P., Mosekilde L. Etidronate disodium in the management of malignancy-related hypercalcemia. Am J Med. 1987 Feb 23;82(2A):51–54. doi: 10.1016/0002-9343(87)90487-6. [DOI] [PubMed] [Google Scholar]
- Heath D. A. Hypercalcaemia in malignancy. BMJ. 1989 Jun 3;298(6686):1468–1469. doi: 10.1136/bmj.298.6686.1468. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heller S. R., Hosking D. J. Renal handling of calcium and sodium in metastatic and non-metastatic malignancy. Br Med J (Clin Res Ed) 1986 Mar 1;292(6520):583–586. doi: 10.1136/bmj.292.6520.583. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ralston S. H., Alzaid A. A., Gallacher S. J., Gardner M. D., Cowan R. A., Boyle I. T. Clinical experience with aminohydroxypropylidene bisphosphonate (APD) in the management of cancer-associated hypercalcaemia. Q J Med. 1988 Oct;68(258):825–834. [PubMed] [Google Scholar]
- Ralston S. H., Alzaid A. A., Gardner M. D., Boyle I. T. Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin. Br Med J (Clin Res Ed) 1986 Jun 14;292(6535):1549–1550. doi: 10.1136/bmj.292.6535.1549. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ralston S. H., Fogelman I., Gardiner M. D., Boyle I. T. Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy. Br Med J (Clin Res Ed) 1984 May 12;288(6428):1405–1408. doi: 10.1136/bmj.288.6428.1405. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ralston S. H., Fogelman I., Gardner M. D., Dryburgh F. J., Cowan R. A., Boyle I. T. Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium. Clin Sci (Lond) 1984 Feb;66(2):187–191. doi: 10.1042/cs0660187. [DOI] [PubMed] [Google Scholar]
- Sleeboom H. P., Bijvoet O. L., van Oosterom A. T., Gleed J. H., O'Riordan J. L. Comparison of intravenous (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate and volume repletion in tumour-induced hypercalcaemia. Lancet. 1983 Jul 30;2(8344):239–243. doi: 10.1016/s0140-6736(83)90231-3. [DOI] [PubMed] [Google Scholar]